Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:20 PM
Ignite Modification Date:
2026-03-26 @ 3:20 PM
NCT ID:
NCT07387302
Eligibility Criteria:
Inclusion Criteria:
* Adult complement inhibitor naïve PNH patients (age\>=18), which is confirmed by flow cytometry evaluation
* Must be vaccinated against meningococcal vaccine and pneumococcal vaccine
Exclusion Criteria:
* Significant bone marrow failure
* Meningitidis infection or unresolved meningococcal disease
* Other significant systemic diseases that might have impact on efficacy and safety assessment
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT07387302
Study Brief:
Protocol Section:
NCT07387302